Aspect Biosystems
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics for regenerative medicine. Their full-stack platform integrates AI-powered bioprinting, design tools, therapeutic cells, and biomaterials to create next-generation cell therapies for metabolic and endocrine diseases. The company aims to deliver functional cures for serious diseases.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $115M
Date: 08-Jan-2025
Investors: Dimension, Novo Nordisk, Radical Ventures, an undisclosed leading global investment firm, InBC, Pallasite Ventures, Pangaea Ventures, Rhino Ventures, T1D Fund: A Breakthrough T1D Venture
Markets: Biotechnology, Regenerative Medicine, Cell Therapy, Tissue Engineering
HQ: Vancouver, British Columbia, Canada
Founded: 2013
Website: http://www.aspectbiosystems.com
LinkedIn: https://ca.linkedin.com/company/aspect-biosystems
Twitter: https://twitter.com/aspectbiosys
Crunchbase: https://www.crunchbase.com/organization/aspect-biosystems
Leave a Comment
Comments
No comments yet.